# Natural Product-Induced Modulation of Androstenone Metabolism in Porcine Hepatocytes

**Authors:** Christine Bone, E. James Squires

PMC · DOI: 10.3390/ani15152199 · Animals : an Open Access Journal from MDPI · 2025-07-25

## TL;DR

This study explores how natural compounds from garlic and guggul plant can help reduce boar taint in pigs by affecting liver metabolism.

## Contribution

The study identifies diallyl sulfide and (Z)-guggulsterone as potential natural treatments for boar taint based on their effect on androstenone metabolism in boar liver cells.

## Key findings

- Diallyl sulfide and (Z)-guggulsterone increased androstenone breakdown in some boar liver cells.
- UGT1A6 was upregulated by PXR and CAR agonists and downregulated by FXR agonists.
- Positive responders had lower basal expression of UGT2B31 and higher expression of FXR and PXR compared to non-responders.

## Abstract

Natural product-derived compounds have been increasingly studied for their potential to treat metabolic diseases. They may also be effective treatments for boar taint, a metabolic issue in intact male pigs (boars), which negatively impacts pork quality. Using cells isolated from boar livers, we found that diallyl sulfide (from garlic) and (Z)-guggulsterone (from the guggul plant) increased the breakdown of androstenone, the primary compound responsible for boar taint. However, these treatments were only effective in a subset of animals. Future feeding trials are warranted to evaluate the efficacy of these natural products as dietary interventions for boar taint and to identify markers that can distinguish animals likely to respond to treatment from those that will not.

The nuclear receptors pregnane X receptor (PXR), constitutive androstane receptor (CAR), and farnesoid X receptor (FXR) regulate the hepatic metabolism of androstenone, a testicular steroid that accumulates in the fat of intact male pigs and causes boar taint. This study evaluated natural product-derived compounds and conventional agonists targeting these nuclear receptors for their effects on androstenone metabolism in primary hepatocytes from slaughter-weight boars, to assess their potential as treatments for boar taint. Cells were incubated with natural products, conventional agonists, or dimethyl sulfoxide (DMSO; control), then being treated with androstenone. Culture media and cells were analyzed to assess changes in androstenone metabolism and gene expression. UGT1A6 was upregulated by treatments targeting both PXR and CAR and downregulated by FXR agonists. Additionally, PGC1α and NR2F1 were downregulated by compounds targeting PXR/CAR, while FXR and NR0B2 were upregulated and HNF4α downregulated by treatments acting on FXR. The natural products diallyl sulfide (DAS) and (Z)-guggulsterone (GUG) increased overall androstenone metabolism (DAS, GUG) and the production of Phase I androstenol metabolites (DAS), but only in hepatocyte culture replicates that responded positively to these treatments. Although gene expression was similar between positive-response and negative/non-responsive replicates following treatments, negative/non-responsive replicates for several treatments had higher basal expression of UGT2B31, UGT2A1, and SIRT1 and lower basal expression of FXR, PXR, and NR0B1 compared to positive-response replicates. These findings suggest that DAS and GUG may be promising treatments for boar taint, specifically in animals with lower basal rates of androstenone metabolism and higher expression of key nuclear receptors.

## Linked entities

- **Genes:** UGT1A6 (UDP glucuronosyltransferase family 1 member A6) [NCBI Gene 54578], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], NR2F1 (nuclear receptor subfamily 2 group F member 1) [NCBI Gene 7025], NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971], NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 8431], HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172], UGT2B31 (UDP-glucuronosyltransferase UGT2B31) [NCBI Gene 442984], UGT2A1 (UDP glucuronosyltransferase family 2 member A1 complex locus) [NCBI Gene 10941], SIRT1 (sirtuin 1) [NCBI Gene 23411], NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 8856], NR0B1 (nuclear receptor subfamily 0 group B member 1) [NCBI Gene 190]
- **Chemicals:** diallyl sulfide (PubChem CID 11617), Z-guggulsterone (PubChem CID 6450278), androstenone (PubChem CID 6852393), androstenol (PubChem CID 101989), dimethyl sulfoxide (PubChem CID 679)
- **Species:** Sus scrofa (taxon 9823)

## Full-text entities

- **Genes:** UGT1A6 (UDP glucuronosyltransferase 1 family, polypeptide A6) [NCBI Gene 100152603] {aka mpugt1A6}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 397013] {aka PGC1, PGC1A, PPARGC-1, PPARGC1}, NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 100526226] {aka SHP}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 733636] {aka HNF-4alpha}, SIRT1 (sirtuin 1) [NCBI Gene 751859], NR2F1 (nuclear receptor subfamily 2 group F member 1) [NCBI Gene 100621341], NR1I3 (nuclear receptor subfamily 1 group I member 3) [NCBI Gene 654317] {aka CAR}, LOC100624788 (UDP-glucuronosyltransferase 2A1) [NCBI Gene 100624788] {aka UGT2A1}, NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 397228] {aka PXR}, UGT2B31 (UDP-glucuronosyltransferase 2B31) [NCBI Gene 100514063], NR0B1 (nuclear receptor subfamily 0 group B member 1) [NCBI Gene 397680] {aka AHC, DAX-1}
- **Chemicals:** androstenol (MESH:D000737), DAS (MESH:C038491), (Z)-guggulsterone (MESH:C023617), steroid (MESH:D013256), DMSO (MESH:D004121), Androstenone (MESH:C000214)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Suidae (boars, family) [taxon 9821]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12345468/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12345468/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12345468/full.md

---
Source: https://tomesphere.com/paper/PMC12345468